Accès gratuit
Numéro
Med Sci (Paris)
Volume 26, Numéro 2, Février 2010
Page(s) 165 - 170
Section M/S revues
DOI https://doi.org/10.1051/medsci/2010262165
Publié en ligne 15 février 2010
  1. Beaulieu JM, Sotnikova TD, Marion S, et al. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell 2005; 122 : 261–73.
  2. Deng YP, Lei WL, Reiner A. Differential perikaryal localization in rats of D1 and D2 dopamine receptors on striatal projection neuron types identified by retrograde labeling. J Chem Neuroanat 2006; 32 : 101–16.
  3. Rashid AJ, So CH, Kong MM, et al. D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum. Proc Natl Acad Sci USA 2007; 104 : 654–9.
  4. Fuxe K, Ferre S, Genedani S, et al. Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function. Physiol Behav 2007; 92 : 210–7.
  5. Azdad K, Gall D, Woods AS, et al. Dopamine D2 and adenosine A2A receptors regulate NMDA-mediated excitation in accumbens neurons through A2A-D2 receptor heteromerization. Neuropsychopharmacology 2009; 34 : 972–86.
  6. Baragli A, Alturaihi H, Watt HL, et al. Heterooligomerization of human dopamine receptor 2 and somatostatin receptor 2 Co-immunoprecipitation and fluorescence resonance energy transfer analysis. Cell Signal 2007; 19 : 2304–16.
  7. Juhasz JR, Hasbi A, Rashid AJ, et al. Mu-opioid receptor heterooligomer formation with the dopamine D1 receptor as directly visualized in living cells. Eur J Pharmacol 2008; 581 : 235–43.
  8. Metaye T, Perdrisot R, Kraimps JL. GRKs and arrestins: the therapeutic pathway ? Med Sci (Paris) 2006; 22 : 537–43.
  9. Namkung Y, Sibley DR. Protein kinase C mediates phosphorylation, desensitization, and trafficking of the D2 dopamine receptor. J Biol Chem 2004; 279 : 49533–41.
  10. St-Gelais F, Jomphe C, Trudeau LE. The role of neurotensin in central nervous system pathophysiology: what is the evidence ? J Psychiatry Neurosci 2006; 31 : 229–45.
  11. Jomphe C, Lemelin PL, Okano H, et al. Bidirectional regulation of dopamine D2 and neurotensin NTS1 receptors in dopamine neurons. Eur J Neurosci 2006; 24 : 2789–800.
  12. Parish CL, Stanic D, Drago J, et al. Effects of long-term treatment with dopamine receptor agonists and antagonists on terminal arbor size. Eur J Neurosci 2002; 16 : 787–94.
  13. Fasano C, Poirier A, DesGroseillers L, Trudeau LE. Chronic activation of the D2 dopamine autoreceptor inhibits synaptogenesis in mesencephalic dopaminergic neurons in vitro. Eur J Neurosci 2008; 28: 1480–90.
  14. Hill JJ, Hashimoto T, Lewis DA. Molecular mechanisms contributing to dendritic spine alterations in the prefrontal cortex of subjects with schizophrenia. Mol Psychiatry 2006; 11 : 557–66.
  15. Day M, Wang Z, Ding J, et al. Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci 2006; 9 : 251–9.
  16. Li Y, Kolb B, Robinson TE. The location of persistent amphetamine-induced changes in the density of dendritic spines on medium spiny neurons in the nucleus accumbens and caudate-putamen. Neuropsychopharmacology 2003; 28 : 1082–5.
  17. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Brain Res Rev 1993; 18 : 247–91.
  18. Bonci A, Malenka RC. Properties and plasticity of excitatory synapses on dopaminergic and GABAergic cells in the ventral tegmental area. J Neurosci 1999; 19 : 3723–30.
  19. Ungless MA, Whistler JL, Malenka RC, Bonci A. Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature 2001; 411 : 583–7.
  20. Saal D, Dong Y, Bonci A, Malenka RC. Drugs of abuse and stress trigger a common synaptic adaptation in dopamine neurons. Neuron 2003; 37 : 577–82.
  21. Liu QS, Pu L, Poo MM. Repeated cocaine exposure in vivo facilitates LTP induction in midbrain dopamine neurons. Nature 2005; 437 : 1027–31.
  22. Luu P, Malenka RC. Spike timing-dependent long-term potentiation in ventral tegmental area dopamine cells requires PKC. J Neurophysiol 2008; 100 : 533–8.
  23. Argilli E, Sibley DR, Malenka RC, et al. Mechanism and time course of cocaine-induced long-term potentiation in the ventral tegmental area. J Neurosci 2008; 28 : 9092–100.
  24. Trudeau LE. Glutamate co-transmission as an emerging concept in monoamine neuron function. J Psychiatry Neurosci 2004; 29 : 296–310.
  25. Kaneko T, Akiyama H, Nagatsu I, Mizuno N. Immunohistochemical demonstration of glutaminase in catecholaminergic and serotoninergic neurons of rat brain. Brain Res 1990; 507 : 151–4.
  26. Sulzer D, Joyce MP, Lin L, et al. Dopamine neurons make glutamatergic synapses in vitro. J Neurosci 1998; 18 : 4588–602.
  27. Takamori S, Rhee JS, Rosenmund C, Jahn R. Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature 2000; 407 : 189–94.
  28. Dal Bo G, St-Gelais F, Danik M, et al. Dopamine neurons in culture express VGLUT2 explaining their capacity to release glutamate at synapses in addition to dopamine. J Neurochem 2004; 88 : 1398–405.
  29. Kawano M, Kawasaki A, Sakata-Haga H, et al. Particular subpopulations of midbrain and hypothalamic dopamine neurons express vesicular glutamate transporter 2 in the rat brain. J Comp Neurol 2006; 498 : 581–92.
  30. Mendez JA, Bourque MJ, Dal Bo G, et al. Developmental and target-dependent regulation of vesicular glutamate transporter expression by dopamine neurons. J Neurosci 2008; 28 : 6309–18.
  31. Descarries L, Watkins KC, Garcia S, Bosler O, Doucet G. Dual character, asynaptic and synaptic, of the dopamine innervation in adult rat neostriatum: a quantitative autoradiographic and immunocytochemical analysis. J Comp Neurol 1996; 375 : 167–86.
  32. Dal Bo G, Bérubé-Carrière N, Mendez JA, et al. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion. Neuroscience 2008; 156 : 59–70.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.